[HTML][HTML] British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of …

JR Hurst, N Verma, D Lowe, HE Baxendale… - The Journal of Allergy …, 2017 - Elsevier
A proportion of people living with common variable immunodeficiency disorders develop
granulomatous-lymphocytic interstitial lung disease (GLILD). We aimed to develop a …

Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies

M Bonifazi, F Bravi, S Gasparini, C La Vecchia… - Chest, 2015 - Elsevier
BACKGROUND An increased cancer risk in patients with sarcoidosis has been suggested,
although results are conflicting in a number of case-control and cohort studies. We …

[HTML][HTML] Cough in idiopathic pulmonary fibrosis

MJG Van Manen, SS Birring, C Vancheri… - European …, 2016 - Eur Respiratory Soc
Many patients with idiopathic pulmonary fibrosis (IPF) complain of chronic refractory cough.
Chronic cough is a distressing and disabling symptom with a major impact on quality of life …

Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline

G Raghu, M Remy-Jardin, CJ Ryerson… - American journal of …, 2020 - atsjournals.org
Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …

Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the …

X Shi-Wen, Y Chen, CP Denton… - Molecular biology of …, 2004 - Am Soc Cell Biol
The endothelins are a family of endothelium-derived peptides that possess a variety of
functions, including vasoconstriction. Endothelin-1 (ET-1) is up-regulated during tissue …

Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes

TL Reddy, M Tominaga, DM Hansell… - European …, 2012 - Eur Respiratory Soc
Pleuroparenchymal fibroelastosis (PPFE) is a rare condition characterised by predominantly
upper lobe pleural and subjacent parenchymal fibrosis, the latter being intra-alveolar with …

Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline

SS Jacobs, JA Krishnan, DJ Lederer… - American journal of …, 2020 - atsjournals.org
Background: Evidence-based guidelines are needed for effective delivery of home oxygen
therapy to appropriate patients with chronic obstructive pulmonary disease (COPD) and …

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

PM George, P Spagnolo, M Kreuter… - The lancet Respiratory …, 2020 - thelancet.com
Within the spectrum of fibrosing interstitial lung diseases (ILDs) is a subset of patients who
have inexorable progression of pulmonary fibrosis despite treatment, which is known as the …

Short‐term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis

NS Goh, RK Hoyles, CP Denton… - Arthritis & …, 2017 - Wiley Online Library
Objective To determine the prognostic value of pulmonary function test (PFT) trends at 1 and
2 years in interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Methods …

Rituximab in severe, treatment‐refractory interstitial lung disease

GJ Keir, TM Maher, D Ming, R Abdullah… - …, 2014 - Wiley Online Library
Background and objective In patients with severe interstitial lung disease (ILD) progressing
despite conventional immunosuppression, rituximab, a B‐lymphocyte depleting monoclonal …